A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral bisphosphonate treatment on bone mineral density in osteopenic women receiving adjuvant aromatase inhibitors: Interim analysis of “BONADIUV” trial.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS658-TPS658 ◽  
Author(s):  
Vieri Scotti ◽  
Icro Meattini ◽  
Sara Cecchini ◽  
Maria Laura De Feo ◽  
Calogero Saieva ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Phase Ii ◽  
Aromatase Inhibitors ◽  
Interim Analysis ◽  
Phase Ii Study ◽  
Bisphosphonate Treatment ◽  
Mineral Density ◽  
Oral Bisphosphonate ◽  
The Impact ◽  
Single Blind

BONADIUV trial: A single blind, randomized placebo controlled phase II study using oral ibandronate for osteopenic women receiving adjuvant aromatase inhibitors: Final safety analysis.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12043-e12043 ◽  
Author(s):  
Lorenzo Livi ◽  
Icro Meattini ◽  
Vieri Scotti ◽  
Calogero Saieva ◽  
Isacco Desideri ◽  
...  
Keyword(s):  
Phase Ii ◽  
Aromatase Inhibitors ◽  
Phase Ii Study ◽  
Safety Analysis ◽  
Single Blind

Genetic determinants of bone mineral density loss in aromatase inhibitors treatment in the B-ABLE Cohort

2014 ◽  
Author(s):  
Maria Rodriguez-Sanz ◽  
Natalia Garcia-Giralt ◽  
Pliego Elisa Torres-del ◽  
Daniel Prieto-Alhambra ◽  
Sonia Servitja ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Aromatase Inhibitors ◽  
Genetic Determinants ◽  
Mineral Density ◽  
Bone Mineral Density Loss
Sign in / Sign up

Export Citation Format

Share Document